Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 8 of 8 for “"siRNA therapeutics"”.

  1. Development of Targeted siRNA Therapeutics for Triple Negative Breast Cancer and Liver Fibrosis

    … systems to deliver small interfering RNA (siRNA) for the treatment of triple negative breast cancer (TNBC) and liver fibrosis. siRNAs targeting vascular endothelial growth factor (VEGF) and IκB kinase ε (IKBKE) were used for treating TNBC, while siRNA targeting poly(rC) binding protein 2 …

    umkc Repository record for Development of Targeted siRNA Therapeutics for Triple Negative Breast Cancer and Liver Fibrosis (opens in a new tab)

  2. Mouse Models of Inherited Skin Diseases

    … mutant KRT9 allele with short interfering RNAs (siRNAs) was explored as a potential therapeutic approach. This led to the development and in vitro validation of potent mutation- and gene-specific siRNA inhibitors. <br/>Despite its importance in EPPK, little is known about the physical requirement …

    dundee Repository record for Mouse Models of Inherited Skin Diseases (opens in a new tab)

  3. Tumor-penetrating delivery of small interfering RNA therapeutics

    … "delivery" challenge, as small interfering RNA (siRNA) therapeutics must overcome clearance mechanisms and penetrate into tumor tissues to access cancer cells. This thesis sought to develop nanotechnology-based platforms to rapidly discover and validate cancer targets in vivo. First, we developed …

    mit Repository record for Tumor-penetrating delivery of small interfering RNA therapeutics (opens in a new tab)

  4. Multifunctional Chemical Cross-linkers for Drug Carriers and Molecular Probes

    … vesicles and quantify endosomal escape for siRNA therapeutics. Taken together, these works highlight the importance of chemical cross-linkers in the design of multifunctional bioconjugates for a variety of applications.

    cornell Repository record for Multifunctional Chemical Cross-linkers for Drug Carriers and Molecular Probes (opens in a new tab)

  5. Development and characterization of chemical modifications for siRNA strand selection

    Small interfering RNA (siRNA) are non-coding, double-stranded RNA that enable efficient gene silencing through RNA interference (RNAi) mechanisms. The primary effector of RNAi is an RNA-guided nuclease, Ago2, which selects one of the two strands as a guide to form the RNA induced silencing complex …

    uoit Repository record for Development and characterization of chemical modifications for siRNA strand selection (opens in a new tab)

  6. Engineering multimodal nanoparticles to combat triple-negative breast cancer

    … compared to other subtypes. Many current chemotherapeutics used to treat TNBC are nonspecific, and, therefore, cause off-target effects and fail to elicit a robust tumor response, which results in higher mortality and recurrence rates. Targeted therapy enabled by nanoparticle (NP)-based drug …

    udel Repository record for Engineering multimodal nanoparticles to combat triple-negative breast cancer (opens in a new tab)

  7. RNA Therapeutics for Fibrolamellar Hepatocellular Carcinoma

    … to synthesize small interfering RNAs (siRNAs) with state-of-the-art chemical modifications. Multiple siRNA therapeutics targeting genes in the liver have been FDA approved. The majority of these use a carbohydrate group, GalNAc, that binds to the asialoglycoprotein receptor (ASGR), …

    rockefeller Repository record for RNA Therapeutics for Fibrolamellar Hepatocellular Carcinoma (opens in a new tab)